|
|
||||||||
1 Thoracic Surgery, 2 Pulmonary Medicine, and 3 Basic Medical Science, Kanazawa Medical University, Uchinada, Ishikawa 920 - 0293, Japan
| |
ABSTRACT |
|---|
|
|
|---|
There is little information regarding the
effect of hypoxia on alveolar fluid clearance capacity. We measured
alveolar fluid clearance, lung water volume, plasma catecholamine
concentrations, and serum osmolality in rats exposed to 10% oxygen for
up to 120 h and explored the mechanisms responsible for the
increase in alveolar fluid clearance. The principal results were
1) alveolar fluid clearance did not change for 48 h and
then increased between 72 and 120 h of exposure to hypoxia;
2) although nutritional impairment during hypoxia decreased
basal alveolar fluid clearance, endogenous norepinephrine increased net
alveolar fluid clearance; 3) the changes of lung water
volume and serum osmolality were not associated with those of alveolar
fluid clearance; 4) an administration of
-adrenergic
agonists further increased alveolar fluid clearance; and 5)
alveolar fluid clearance returned to normal within 24 h of
reoxygenation after hypoxia. In conclusion, alveolar epithelial fluid
transport capacity increases in rats exposed to hypoxia. It is likely
that a combination of endogenous norepinephrine and nutritional
impairment regulates alveolar fluid clearance under hypoxic conditions.
catecholamine; fluid balance; alveolar epithelium; denopamine
| |
INTRODUCTION |
|---|
|
|
|---|
ALVEOLAR FLUID
CLEARANCE CAPACITY is inversely associated with mortality in
patients with pulmonary edema (19). Recently, it was
reported that the stimulation of alveolar fluid clearance accelerated
the resolution of pulmonary edema and facilitated gas exchange across
the alveolar epithelium (9). The initial step in alveolar
fluid clearance is to transport alveolar sodium through apical sodium
channels into the alveolar epithelial cells, then to exchange sodium
and potassium through basolateral Na+-K+-ATPase
(3, 6, 17, 18, 29, 31). Osmotic gradients created by those
transported ions drive alveolar fluid across the alveolar epithelium
(18). Amiloride inhibits apical sodium channels
(16), and
-adrenergic agonists accelerate sodium and fluid transport (1, 17, 18, 31). Endogenous catecholamines increase alveolar fluid clearance in rats with septic (21)
and hemorrhagic shock (20) and in dogs with neurogenic
pulmonary edema (14).
The effect of hypoxia on alveolar epithelial fluid transport is an
important issue because alveolar spaces are exposed to hypoxia in
patients with pulmonary edema or during ascent to high altitudes
(5). Hypoxia induced a downregulation of the expression and activity of sodium channels and
Na+-K+-ATPase in cultured type II alveolar
epithelial cells from rat lungs and in A549 cells (15, 22,
23). However, the oxygen concentrations used in those studies
were too low (
3% oxygen) to replicate in an in vivo study. Recently,
Suzuki et al. (32) reported that alveolar fluid clearance
decreased in rats exposed to 10% oxygen for 72 h. However, their
results are inconsistent with the report that
5% oxygen did not
change the expression and activity of sodium channels and
Na+-K+-ATPase in cultured type II cells
(22).
The objectives in this study were to determine 1) whether
hypoxia affected alveolar fluid transport capacity and lung water volume in rat lungs, 2) the mechanisms responsible for such
an increase in alveolar fluid clearance, 3) whether
-adrenergic agonists could further increase alveolar fluid clearance
in rats exposed to hypoxia, and 4) whether alveolar fluid
clearance returned to normal after reoxygenation following hypoxia.
| |
METHODS |
|---|
|
|
|---|
Materials
Materials were obtained as follows: denopamine from Tanabe Pharmaceutical (Tokyo, Japan); salmeterol from Glaxo Wellcome (Middlesex, UK); Evans blue from Tokyo Kasei (Tokyo, Japan); and amiloride, norepinephrine, phentolamine, and propranolol from Sigma Chemical (St. Louis, MO).General Protocol
Hypoxic exposure. This study was approved by the Animal Care Committee in Kanazawa Medical University. Specific pathogen-free Sprague-Dawley rats (250-300 g, Japan SLC, Hamamatsu, Japan) were exposed to normobaric hypoxia (10% oxygen) for up to 120 h in a sealed chamber that was continuously flooded with hypoxic gas at 6 l/min (low oxygen generator, Teijin, Tokyo, Japan). Oxygen concentration in the chamber was analyzed twice a day with an oxygen analyzer (TED 60T, Teledyne Brown Engineering, City of Industry, CA). The rats were permitted access to food and water ad libitum.
Measurement of alveolar fluid clearance. We isolated the rat lungs and measured alveolar fluid clearance in the absence of either pulmonary perfusion or ventilation as previously reported (24, 27, 28). Briefly, rats were anesthetized by intraperitoneal administration of pentobarbital sodium (50 mg/kg). An endotracheal tube was inserted through a tracheostomy. Blood samples for the measurements of plasma catecholamines and serum osmolality were obtained from the abdominal aorta, and rats were exsanguinated. Through a median sternotomy, the left hilum was ligated with a silk suture and the left lung was isolated for the subsequent measurement of lung water-to-dry lung weight ratio (LW/DL). The trachea, right lung, and heart were excised en bloc. The isolated lungs were wrapped in Saran Wrap to prevent dehydration and placed in a humidified incubator at 37°C. The lungs were ventilated with 100% nitrogen (5 cycles) before instillation to remove oxygen from the alveolar spaces. A warmed physiological saline solution (0.7 ml/kg, 37°C) containing 5% albumin and Evans blue dye (0.15 mg/ml) was instilled into the alveolar spaces through the endotracheal tube. After instillation, the lungs were inflated with 100% nitrogen at an airway pressure of 7 cmH2O. Alveolar fluid was aspirated 1 h after instillation. The concentrations of Evans blue-labeled albumin in the instilled and aspirated solutions were measured by a spectrophotometer at a wavelength of 621 nm (BioSpec-1600, Shimadzu, Kyoto, Japan). By using trichloroacetic acid, >99.5% of Evans blue dye was bound to albumin in the instilled and aspirated solutions.
Alveolar fluid clearance was estimated by the progressive increase in the concentration of alveolar Evans blue-labeled albumin (24, 27, 28). Alveolar fluid clearance (AFC) was calculated as follows
|
|
Measurement of lung water volume.
Water volume in the left lung was measured by drying the isolated lung
to a constant weight at 70°C for 48 h. LW/DL was calculated as
LW/DL = (wet lung weight
dry lung weight)/(dry lung weight).
Plasma catecholamine concentrations.
Blood samples were obtained from the abdominal aorta and transferred
immediately to chilled tubes containing 0.02 ml heparin sodium. The
blood samples were then centrifuged (1,200 g, 10 min, 4°C), and the plasma samples were separated and stored at
80°C. Plasma catecholamine concentrations were determined by high-performance liquid chromatography with a trihydroxyindole reaction.
Serum osmolality. Serum osmolality was measured by a freezing-point depression method using an osmometer (Fiske one-ten osmometer, Fiske Associates, Norwood, MA).
Specific Protocol
Group 1: effects of deoxygenation on alveolar oxygen tension and alveolar fluid clearance (n = 18). We determined whether the alveolar spaces were hypoxic during the measurement and whether deoxygenation of the albumin solutions would alter alveolar fluid clearance in rats not exposed to 10% oxygen. We instilled 5% albumin solution exposed to room air for 2 h at 37°C before instillation (n = 7) or 5% albumin solution in which oxygen was removed with 100% nitrogen for 2 h at 37°C before instillation (n = 4). After instillation, the lungs were inflated with 100% nitrogen for 1 h. As controls, the lungs were inflated with 100% oxygen for 1 h at 37°C after instillation of the albumin solution (n = 7). Alveolar fluid clearance and oxygen partial pressure in the instilled albumin solution were measured 5 min and 1 h after instillation. Because Evans blue dye could not be used in a blood gas analyzer, an albumin solution without Evans blue dye was used in this group. Alveolar fluid clearance was estimated by the progressive increase in the albumin concentration measured by a spectrophotometer at a wavelength of 280 nm.
Group 2: time course of alveolar fluid clearance and lung water volume in rats exposed to hypoxia (n = 41). Alveolar fluid clearance, LW/DL, plasma catecholamine and cortisol concentrations, and serum osmolality were measured in rats exposed to hypoxia (10% oxygen) for 3 h (n = 4), 48 h (n = 7), 72 h (n = 7), 96 h (n = 6), and 120 h (n = 7) and in rats not exposed to hypoxia (n = 10, as controls).
Group 3: effects of a sodium channel inhibitor on alveolar fluid
clearance in rats exposed to hypoxia (n = 12).
Inasmuch as alveolar fluid clearance increased in rats exposed to
hypoxia (10% oxygen) for 120 h, we determined whether increased alveolar fluid clearance depended on amiloride-sensitive sodium channels. An albumin solution containing amiloride (5 × 10
4 M), a sodium channel inhibitor, was instilled in rats
exposed to hypoxia for 120 h (n = 6) and in rats
not exposed to hypoxia (n = 6).
Group 4: effects of nutritional deprivation on alveolar fluid clearance and lung water volume (n = 12). Intake of food and water was impaired during hypoxia (10% oxygen). Weight gain over 120 h was 30 ± 10 (SD) g less in rats exposed to hypoxia than in rats not exposed to hypoxia. Therefore, we tested the hypothesis that nutritional impairment increased serum osmolality and resulted in the increase in alveolar fluid clearance in rats exposed to hypoxia because osmotic gradients between the alveolar spaces and the pulmonary vasculature drove the alveolar fluid across the alveolar epithelial barrier (18). Alveolar fluid clearance, LW/DL, plasma catecholamine concentrations, and serum osmolality were measured in rats exposed to nutritional deprivation under normoxic conditions for 120 h (n = 7) and in rats exposed to nutritional deprivation under hypoxic conditions for 120 h (n = 5). Rats were allowed access to water but not to food. In the measurement of alveolar fluid clearance, the lungs were inflated with 100% nitrogen for 1 h after instillation.
Group 5: effects of
- or
-adrenergic antagonists on
alveolar fluid clearance in rats exposed to hypoxia (n = 22).
We determined whether the increase in alveolar fluid clearance was
mediated by the stimulation of
-adrenoceptors or
-adrenoceptors. An albumin solution containing 10
4 M phentolamine
(n = 5), an
-adrenergic antagonist, or
10
5 M propranolol (n = 5), a
-adrenergic antagonist, was instilled into the alveolar spaces in
rats exposed to hypoxia (10% oxygen) for 120 h. In addition, to
determine whether physiological levels of norepinephrine could further
increase alveolar fluid clearance in rats exposed to hypoxia, an
albumin solution containing 10
7 M norepinephrine was
instilled in rat lungs exposed to hypoxia for 120 h
(n = 4). To determine the effect of phentolamine alone or propranolol alone on alveolar fluid clearance in normal rats, an
albumin solution containing 10
4 M phentolamine
(n = 4) or 10
5 M propranolol
(n = 4) was instilled into the alveolar spaces in rats
not exposed to hypoxia.
Group 6: effects of exogenous norepinephrine on alveolar fluid
clearance in rats exposed to nutritional deprivation (n = 15).
To determine whether the elevated concentrations of plasma
norepinephrine were sufficient to increase alveolar fluid clearance, the effects of exogenous norepinephrine at concentrations similar to
plasma norepinephrine concentrations on alveolar fluid clearance were
determined in rats exposed to nutritional deprivation. An albumin
solution containing 10
8 M (n = 5) or
10
7 M (n = 5) norepinephrine was
instilled in rats exposed to nutritional deprivation for 120 h
under normoxic conditions. In addition, to determine whether the effect
of norepinephrine was mediated by
-adrenoceptors, 10
4
M propranolol (n = 5) was added to an albumin solution
containing 10
7 M norepinephrine and instilled into the
alveolar spaces. After instillation, the lungs were inflated with 100%
nitrogen as described in General Protocol. In five rats with
instillation of 10
7 M norepinephrine, the concentrations
of norepinephrine in the instilled albumin solution were measured
before instillation and 1 h after instillation.
Group 7: potency of exogenous norepinephrine on alveolar fluid
clearance in normal rats (n = 15).
The alveolar fluid clearance rates were slower in rats with nutritional
impairment in the presence of exogenous 10
7 M
norepinephrine and in rats exposed to hypoxia for 120 h than the
rates in rats with an administration of
-adrenergic agonists in the
previous studies (24, 27, 28). Therefore, we determined whether the potency of norepinephrine was lower than that of
-adrenergic agonists. An albumin solution containing
10
5 M norepinephrine was instilled into the normal rat
lungs (n = 5) and the potency of norepinephrine was
compared with that of the identical concentrations of
-adrenergic
agonists (24, 27, 28). In addition, to determine whether
the effect of norepinephrine was mediated by
-adrenoceptors or
-adrenoceptors, 10
4 M phentolamine (n = 5) or 10
4 M propranolol (n = 5) was
added to an albumin solution containing 10
5 M
norepinephrine and instilled into the alveolar spaces. After instillation, the lungs were inflated with 100% nitrogen as described in General Protocol.
Group 8: effects of
-adrenergic agonists on alveolar fluid
clearance in rats exposed to hypoxia (n = 19).
Inasmuch as the rate of alveolar fluid clearance in rats exposed to
hypoxia for 120 h was less than that produced by
-adrenergic agonists in rats not exposed to hypoxia (24, 27, 28), we determined whether exogenous
-adrenergic agonists would further increase alveolar fluid clearance in rats exposed to hypoxia. An
albumin solution containing 10
5 M denopamine, a
selective
1-adrenergic agonist (28), was
instilled in the rat lungs exposed to hypoxia (10% oxygen) for
120 h (n = 5) and in the rat lungs not exposed to
hypoxia (n = 5). In addition, an albumin solution
containing 10
6 M salmeterol, a lipophilic
2-adrenergic agonist (24), was instilled in
the rat lungs exposed to hypoxia for 120 h (n = 5) and in the rat lungs not exposed to hypoxia (n = 4).
Group 9: recovery of alveolar fluid clearance capacity in rats after reoxygenation (n = 5). To determine whether reoxygenation after hypoxia could restore the normal clearance rates, alveolar fluid clearance, LW/DL, plasma catecholamine concentrations, and serum osmolality were measured in rats exposed to normoxia for 24 h after hypoxia (10% oxygen) for 96 h (n = 5).
Statistics
The data are summarized as means and SD. The data were analyzed by one-way ANOVA with Student-Newman-Keuls post hoc test when multiple comparisons were needed. When comparisons were made between two experimental groups, an unpaired Student's t-test was used. We regarded differences with a P value of <0.05 as significant.| |
RESULTS |
|---|
|
|
|---|
Group 1: Effects of Deoxygenation on Alveolar Oxygen Tension and Alveolar Fluid Clearance
In the rat lungs inflated with 100% nitrogen after instillation of the normoxic albumin solutions, the oxygen partial pressure in the alveolar albumin solutions decreased to 75 and 39 Torr at 5 min and 1 h after instillation, respectively. When oxygen in the albumin solution was exchanged with 100% nitrogen for 2 h before instillation, the oxygen partial pressure in the albumin solution before instillation decreased to 50 Torr. Then, the oxygen partial pressure decreased to 36 Torr at 5 min after instillation and was maintained at 36 Torr up to 1 h after instillation. Deoxygenation of the instilled albumin solutions had no effect on alveolar fluid clearance (Fig. 1).
|
Group 2: Time Course of Alveolar Fluid Clearance and Lung Water Volume in Rats Exposed to Hypoxia
Alveolar fluid clearance and lung water volume did not change in rats exposed to hypoxia (10% oxygen) for 3 and 48 h (Fig. 2A). However, alveolar fluid clearance significantly increased in rats exposed to hypoxia for 72, 96, and 120 h. In contrast, LW/DL decreased in rats exposed to hypoxia for 72, 96, and 120 h (Fig. 2B). Plasma norepinephrine concentrations increased significantly in rats exposed to hypoxia for 72, 96, and 120 h (0.9 × 10
8,
1.1 × 10
8, and 1.6 × 10
8 M at
72, 96, and 120 h, respectively; Table
1). There were no major changes in plasma
epinephrine, dopamine, and cortisol concentrations in rats exposed to
hypoxia for 72, 96, and 120 h. Serum osmolality did not change in
rats exposed to hypoxia for 120 h (Table
2).
|
|
|
Group 3: Effects of a Sodium Channel Inhibitor on Alveolar Fluid Clearance in Rats Exposed to Hypoxia
Amiloride decreased alveolar fluid clearance in control rats and in rats exposed to hypoxia (10% oxygen) for 120 h (Fig. 3). The fractions of amiloride-insensitive alveolar fluid clearance were similar in control rats and in rats exposed to hypoxia for 120 h.
|
Group 4: Effects of Nutritional Deprivation on Alveolar Fluid Clearance and Lung Water Volume
Alveolar fluid clearance decreased in rats exposed to nutritional deprivation for 120 h under normoxic conditions (Fig. 4). However, hypoxia (10% oxygen) increased alveolar fluid clearance in rats exposed to nutritional deprivation. The lung water volume decreased in rats exposed to nutritional deprivation as well as in rats exposed to hypoxia for 120 h. An additional exposure to hypoxia did not change the lung water volume in rats exposed to nutritional deprivation. Although serum osmolality did not change in rats exposed to hypoxia for 120 h, the level increased in rats exposed to nutritional deprivation under normoxic and hypoxic conditions for 120 h (Table 2). Body weight loss was larger in rats exposed to nutritional deprivation than in rats exposed to hypoxia for 120 h because rats in the latter group took some diet. Plasma norepinephrine concentrations did not change in rats exposed to nutritional deprivation under normoxic conditions. However, hypoxia increased the plasma norepinephrine concentrations in rats exposed to nutritional deprivation.
|
Group 5: Effects of
- or
-Adrenergic Antagonists on Alveolar
Fluid Clearance in Rats Exposed to Hypoxia
7 M
norepinephrine in rats exposed to hypoxia for 120 h. Propranolol alone or phentolamine alone had no effect on alveolar fluid clearance in rats not exposed to hypoxia.
|
Group 6: Effects of Exogenous Norepinephrine on Alveolar Fluid Clearance in Rats Exposed to Nutritional Deprivation
In rats exposed to nutritional deprivation for 120 h under normoxic conditions, 10
7 M norepinephrine, but not
10
8 M norepinephrine, significantly increased alveolar
fluid clearance (Fig. 6). Propranolol
inhibited alveolar fluid clearance increased by 10
7 M
norepinephrine in rats exposed to nutritional deprivation. Norepinephrine concentrations in the alveolar albumin solution decreased from 15.4 ± 0.4 to 2.3 ± 0.6 ng/ml over 1 h
(from 9.1 × 10
8 to 1.4 × 10
8
M).
|
Group 7: Potency of Exogenous Norepinephrine on Alveolar Fluid Clearance in Normal Rats
In normal rats, 10
5 M norepinephrine increased
alveolar fluid clearance (Fig. 7).
Although the increase was comparable with that observed in rats exposed
to hypoxia for 120 h, the increase was lower than that in the
presence of identical concentrations of terbutaline, denopamine, or
salmeterol (24, 27, 28). Propranolol, but not
phentolamine, inhibited the rates of alveolar fluid clearance increased
by 10
5 M norepinephrine in normal rats (Fig. 7).
|
Group 8: Effects of
-Adrenergic Agonists on Alveolar Fluid
Clearance in Rats Exposed to Hypoxia
|
Group 9: Recovery of Alveolar Fluid Clearance in Rats After Reoxygenation
Alveolar fluid clearance and plasma norepinephrine concentrations returned to normal in rats exposed to normoxia for 24 h after hypoxia (10% oxygen) for 96 h (Fig. 9). However, the lung water volume remained decreased after reoxygenation for 24 h.
|
| |
DISCUSSION |
|---|
|
|
|---|
The major findings in this study are that alveolar fluid transport capacity did not change for 48 h and then increased after 72, 96, and 120 h of exposure to hypoxia with 10% oxygen. These findings are inconsistent with the finding that alveolar fluid clearance decreased in rats exposed to 10% oxygen for 72 h (32) but are consistent with the finding that moderate hypoxia (5% oxygen) had no effect on the sodium channel activity measured by amiloride-sensitive 22Na influx in type II alveolar epithelial cells (22).
Inflation of the lungs with 100% nitrogen reduced oxygen concentration in the alveolar albumin solutions ~5-10% oxygen for 1 h. Deoxygenation of the albumin solution before instillation reduced the oxygen concentration ~5% oxygen. However, deoxygenation before instillation had no effect on alveolar fluid clearance. These results are consistent with the finding that a short term of hypoxia did not affect the alveolar fluid clearance capacity in previous studies (27, 28). One of the limitations in these preparations is that it is impossible to expose the alveolar spaces in the isolated rat lung to more severe hypoxia (<5% oxygen) that can decrease amiloride-sensitive 22Na influx in cultured type II cells (22).
The upregulation of amiloride-sensitive alveolar fluid clearance has
been reported in the rat lungs' responses to several stimuli:
endotoxin (11), keratinocyte growth factor
(33), transforming growth factor-
(8), and
-adrenergic agonists (1, 24, 25, 29). We tested three
hypotheses accounting for the increase in amiloride-sensitive alveolar
fluid clearance in rats exposed to hypoxia. The first hypothesis was
the effect of osmotic gradients (18). Recently, Fukuda et
al. (10) evaluated the effect of osmotic difference
between the alveolar spaces and the pulmonary vasculature on alveolar
fluid clearance in the mouse lung. The difference of 65 mosmol/kgH2O resulted in a 20% slower clearance. However,
serum osmolality did not increase in rats exposed to hypoxia for
120 h in this study. Therefore, it is unlikely that serum
osmolality played a role in the increase in alveolar fluid clearance.
The second hypothesis was that the decrease in the lung water volume played a role in the increase in alveolar fluid clearance in rats exposed to hypoxia. Fukuda et al. (10) also reported that lung interstitial fluid volume representing a part of lung water volume played an important role in the regulation of alveolar fluid clearance in the in situ mouse lung model. However, the changes of alveolar fluid clearance were not consistent with those of lung water volume in this study. For example, the lung water volume remained decreased, but alveolar fluid clearance returned to normal after reoxygenation for 24 h following hypoxia for 96 h. Therefore, it is also unlikely that the decrease in the lung water volume played a primary role in the increase in alveolar fluid clearance in rats exposed to hypoxia.
Did the increase in alveolar fluid clearance result in a reduction of
the lung water volume? Alveolar fluid clearance measured by the
progressive increase in the alveolar albumin concentration changed in
parallel with lung fluid clearance measured by lung water volume
(1, 2, 12, 14, 21). The stimulation of alveolar fluid
clearance by salmeterol, a
2-adrenergic agonist, resulted in a 62% reduction of excess lung water volume as well as a
significant improvement in arterial blood gases (9). In the present study, the lung water volume was inversely related to the
alveolar fluid clearance rates (Fig. 2). These results support the
hypothesis that the increase in alveolar fluid clearance can decrease
the lung water volume. However, as observed in rats exposed to
nutritional deprivation, an additional exposure to hypoxia increased
both plasma norepinephrine concentrations and alveolar fluid clearance
but did not change the lung water volume. Therefore, it is impossible
to conclude that the increase in alveolar fluid clearance results in a
reduction of the lung water volume.
The third hypothesis was that endogenous catecholamines contributed to the increase in alveolar fluid clearance. Although plasma epinephrine and denopamine levels did not significantly change, norepinephrine concentrations significantly increased, consistent with alveolar fluid clearance (Table 1). The increase in plasma norepinephrine concentration was coincident with the results obtained from a human study in which healthy men were transported to a high altitude (4,559 m) for 120 h (13).
There are three lines of evidence that support a role of endogenous
norepinephrine in increased alveolar fluid clearance in rats exposed to
hypoxia. First, only the plasma norepinephrine concentration changed in
association with alveolar fluid clearance. Second, propranolol, but not
phentolamine, inhibited the increase in alveolar fluid clearance. The
results indicated that increased clearance was mediated by
-adrenoceptors, not by
-adrenoceptors. In addition, exogenous
norepinephrine increased alveolar fluid clearance via
-adrenoceptors. These data are consistent with
-adrenoceptor-mediated alveolar fluid clearance in the in vivo lung
(18) and sodium transport in cultured type II cells
(17). Third, the magnitude of alveolar fluid clearance in
the presence of 10
5 M norepinephrine in normal rats was
comparable to that in rats exposed to hypoxia for 120 h. However,
the magnitude was less than that in the presence of identical
concentrations of
-adrenergic agonists (24, 27, 28).
We determined whether plasma norepinephrine concentrations were
sufficient to increase alveolar fluid clearance. We found that
10
7 M norepinephrine increased alveolar fluid clearance
by stimulating
-adrenoceptors in rats exposed to nutritional
deprivation. Although the initial concentration (10
7 M)
was higher than the plasma norepinephrine concentration (1-2 × 10
8 M), the final concentration (1.6 × 10
8 M) was comparable to plasma norepinephrine levels in
rats exposed to hypoxia. The norepinephrine concentration decrease was
comparable to the amiloride and salmeterol concentration decreases
(2, 12). The higher norepinephrine concentrations are
consistent with the results that denopamine and salmeterol higher than
10
7 M were necessary to increase alveolar fluid clearance
(24, 28). Therefore, it is likely that endogenous
norepinephrine concentration was sufficient to increase some alveolar
fluid clearance in rats exposed to hypoxia.
The results in this study are inconsistent with the finding that
endogenous or exogenous norepinephrine did not stimulate alveolar fluid
clearance in dog lungs (14, 16). Because alveolar fluid
clearance was slower in dogs and faster in rats (18), it
is likely that the effect of norepinephrine was masked in the dog
lungs. In the present study, it is uncertain whether hypoxia or
nutritional deprivation increased sensitivity of
-adrenoceptors.
Although alveolar fluid clearance was slower in rats exposed to hypoxia
for 120 h than in normal rats with the treatment of denopamine and
salmeterol (24, 28), these agonists increased alveolar
fluid clearance to normal levels in rats exposed to hypoxia. These
results suggest that the response to
-adrenergic agonists persisted
at normal levels in rats exposed to hypoxia for 120 h. The
preservation of the response to
-adrenergic agonist is consistent
with that in human lungs exposed to severe hypothermia (26) or in rat lungs exposed to hyperoxia
(30). Therefore, it is likely that
1- and
2-adrenoceptors are resistant to moderate hypoxia (10%
oxygen) for 120 h. The resistance may be beneficial in the
resolution of pulmonary edema when alveolar epithelial cells are
exposed to hypoxia for several days.
Because nutritional impairment was observed in rats exposed to hypoxia, we determined whether nutritional deprivation affected alveolar fluid clearance in rats under normoxic conditions. Nutritional deprivation for 120 h decreased both alveolar fluid clearance and lung water volume but increased serum osmolality and did not change plasma catecholamine concentrations. Therefore, it is likely that nutritional impairment decreased the alveolar fluid transport capacity under normoxic conditions. Then, we proceeded with the study to determine whether hypoxia affected alveolar fluid clearance in rats exposed to nutritional deprivation. Similar to the results in rats in the absence of hypoxia, both alveolar fluid clearance and plasma norepinephrine concentrations increased in the presence of hypoxia and nutritional deprivation. These results suggested that nutritional impairment during the hypoxic exposure decreased alveolar fluid clearance, but endogenous norepinephrine increased net alveolar fluid clearance in rats exposed to hypoxia. Recently, it was reported that continuous nutrition attenuated pulmonary edema in rats exposed to 100% oxygen (7). Taken together, nutritional improvement may be important in the resolution of pulmonary edema as well as in the attenuation of the development of pulmonary edema.
Last, we determined whether alveolar fluid clearance returned to normal within 24 h of reoxygenation after 96 h of hypoxia. We found that plasma norepinephrine concentrations and alveolar fluid clearance returned to normal 24 h after reoxygenation. However, the lung water volume remained decreased. Therefore, the results indicate that the change of alveolar fluid clearance was related to the change of plasma norepinephrine concentrations but not to the lung water volume. The reversibility of alveolar fluid clearance in this study is consistent with the effect of epinephrine on alveolar fluid clearance in anesthetized rats (4).
In summary, alveolar fluid clearance capacity was sustained for 48 h and then increased between 72 and 120 h of exposure to hypoxia
(10% oxygen) in rats. Although nutritional impairment during hypoxia
decreases basal alveolar fluid clearance, the increase in plasma
norepinephrine concentration increased net alveolar fluid clearance by
stimulating
-adrenoceptors. The response to exogenous
1- and
2-adrenergic agonists was
preserved in rats exposed to hypoxia for 120 h. Reoxygenation for
24 h after hypoxia could restore normal alveolar fluid clearance.
It is likely that alveolar epithelial cells are resistant to moderate
hypoxia.
-Adrenergic agonist therapy may be effective in the
resolution of pulmonary edema in patients exposed to hypoxia.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported by Grants from Kanazawa Medical University (C99-3, S00-13) and a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Japan.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: T. Sakuma, Thoracic Surgery, Kanazawa Medical Univ., Uchinada, Ishikawa 920-0293, Japan (E-mail: sakuma-t{at}kanazawa-med.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 12 December 2000; accepted in final form 12 June 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Berthiaume, Y,
Staub NC,
and
Matthay MA.
-Adrenergic agonists increase lung liquid clearance in anesthetized sheep.
J Clin Invest
79:
335-343,
1987.
2.
Campbell, AR,
Folkesson HG,
Berthiaume Y,
Gutkowska J,
Suzuki S,
and
Matthay MA.
Alveolar epithelial fluid clearance persists in the presence of moderate left atrial hypertension in sheep.
J Appl Physiol
86:
139-151,
1999
3.
Carter, EP,
Wangensteen OD,
O'Grady SM,
and
Ingbar DH.
Effects of hyperoxia on type II cell Na-K-ATPase function and expression.
Am J Physiol Lung Cell Mol Physiol
272:
L542-L551,
1997
4.
Charron, PD,
Fawley JP,
and
Maron MB.
Effect of epinephrine on alveolar liquid clearance in the rat.
J Appl Physiol
87:
611-618,
1999
5.
Clerici, C,
and
Matthay MA.
Hypoxia regulates gene expression of alveolar epithelial transport proteins.
J Appl Physiol
88:
1890-1896,
2000
6.
Crandall, ED,
Heming TA,
Palombo RL,
and
Goodman BE.
Effects of terbutaline on sodium transport in isolated perfused rat lung.
J Appl Physiol
60:
289-294,
1986
7.
Factor, P,
Ridge K,
Alverdy J,
and
Sznajder JI.
Continuous enteral nutrition attenuates pulmonary edema in rats exposed to 100% oxygen.
J Appl Physiol
89:
1759-1765,
2000
8.
Folkesson, HG,
Pittet JF,
Nitenberg G,
and
Matthay MA.
Transforming growth factor-
increases alveolar liquid clearance in anesthetized ventilated rats.
Am J Physiol Lung Cell Mol Physiol
271:
L236-L244,
1996
9.
Frank, JA,
Wang Y,
Osorio O,
and
Matthay MA.
-Adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats.
J Appl Physiol
89:
1255-1265,
2000
10.
Fukuda, N,
Folkesson HG,
and
Matthay MA.
Relationship of interstitial fluid volume to alveolar fluid clearance in mice: ventilated vs. in situ studies.
J Appl Physiol
89:
672-679,
2000
11.
Garat, C,
Rezaiguia S,
Meignan M,
d'Ortho MP,
Harf A,
Matthay MA,
and
Jayr C.
Alveolar endotoxin increases alveolar liquid clearance in rats.
J Appl Physiol
79:
2021-2028,
1995
12.
Jayr, C,
Garat C,
Meignan M,
Pittet JF,
Zelter M,
and
Matthay MA.
Alveolar liquid and protein clearance in anesthetized ventilated rats.
J Appl Physiol
76:
2636-2642,
1994
13.
Kanstrup, IL,
Poulsen TD,
Hansen JM,
Andersen LJ,
Bestle MH,
Christensen NJ,
and
Olsen NV.
Blood pressure and plasma catecholamines in acute and prolonged hypoxia: effects of local hypothermia.
J Appl Physiol
87:
2053-2058,
1999
14.
Lane, SM,
Maender KC,
Awender NE,
and
Maron MB.
Adrenal epinephrine increases alveolar liquid clearance in a canine model of neurogenic pulmonary edema.
Am J Respir Crit Care Med
158:
760-768,
1998
15.
Mairbäurl, H,
Wodopia R,
Eckes S,
Schulz S,
and
Bartsch P.
Impairment of cation transport in A549 cells and rat alveolar epithelial cells by hypoxia.
Am J Physiol Lung Cell Mol Physiol
273:
L797-L806,
1997.
16.
Maron, MB.
Dose-response relationship between plasma epinephrine concentration and alveolar liquid clearance in dogs.
J Appl Physiol
85:
1702-1707,
1998
17.
Matalon, S,
Benos DJ,
and
Jackson RM.
Biophysical and molecular properties of amiloride-inhibitable Na+ channels in alveolar epithelial cells.
Am J Physiol Lung Cell Mol Physiol
271:
L1-L22,
1996
18.
Matthay, MA,
Folkesson HG,
and
Verkman AS.
Salt and water transport across alveolar and distal airway epithelia in the adult lung.
Am J Physiol Lung Cell Mol Physiol
270:
L487-L503,
1996
19.
Matthay, MA,
and
Wiener-Kronish JP.
Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.
Am Rev Respir Dis
142:
1250-1257,
1990[ISI][Medline].
20.
Modelska, K,
Matthay MA,
McElroy MC,
and
Pittet JF.
Upregulation of alveolar fluid clearance after fluid resuscitation for hemorrhagic shock in rats.
Am J Physiol Lung Cell Mol Physiol
273:
L305-L314,
1997
21.
Pittet, JF,
Wiener-Kronish JP,
McElroy MC,
Folkesson HG,
and
Matthay MA.
Stimulation of lung epithelial liquid clearance by endogenous release of catecholamines in septic shock in anesthetized rats.
J Clin Invest
94:
663-671,
1994.
22.
Planès, C,
Escoubet B,
Blot-Chabaud M,
Friedlander G,
Farman N,
and
Clerici C.
Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells.
Am J Respir Cell Mol Biol
17:
508-518,
1997
23.
Planès, C,
Friedlander G,
Loiseau A,
Amiel C,
and
Clerici C.
Inhibition of Na-K-ATPase activity after prolonged hypoxia in an alveolar epithelial cell line.
Am J Physiol Lung Cell Mol Physiol
271:
L70-L78,
1996
24.
Sakuma, T,
Folkesson HG,
Suzuki S,
Okaniwa G,
Nakada T,
Fujimura S,
and
Matthay MA.
-Adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs.
Am J Respir Crit Care Med
155:
506-512,
1997[Abstract].
25.
Sakuma, T,
Okaniwa G,
Nakada T,
Nishimura T,
Fujimura S,
and
Matthay MA.
Alveolar fluid clearance in the resected human lung.
Am J Respir Crit Care Med
150:
305-310,
1994[Abstract].
26.
Sakuma, T,
Suzuki S,
Usuda K,
Handa M,
Okaniwa G,
Nakada T,
Fujimura S,
and
Matthay MA.
Alveolar epithelial fluid transport mechanisms are preserved in the rewarmed human lung following severe hypothermia.
J Appl Physiol
80:
1681-1686,
1996
27.
Sakuma, T,
Tsukano C,
Ishigaki M,
Nambu N,
Osanai K,
Toga H,
Takahashi K,
Ohya N,
Kurihara T,
Nishio M,
and
Matthay MA.
Lung deflation impairs alveolar epithelial fluid transport in ischemic rabbit and rat lungs.
Transplantation
69:
1785-1792,
2000[ISI][Medline].
28.
Sakuma, T,
Tuchihara C,
Ishigaki M,
Osanai K,
Nambu Y,
Toga H,
Takahashi K,
Ohya N,
Kurihara T,
and
Matthay MA.
Denopamine, a
1-adrenergic agonist, increases alveolar fluid clearance in ex vivo rat and guinea pig lungs.
J Appl Physiol
90:
10-16,
2001
29.
Saldías, F,
Lecuona E,
Friedman E,
Barnard ML,
Ridge KM,
and
Sznajder JI.
Modulation of lung liquid clearance by isoproterenol in rat lungs.
Am J Physiol Lung Cell Mol Physiol
274:
L694-L701,
1998
30.
Saldías, FJ,
Comellas A,
Ridge KM,
Lecuona E,
and
Sznajder JI.
Isoproterenol improves ability of lung to clear edema in rats exposed to hyperoxia.
J Appl Physiol
87:
30-35,
1999
31.
Saumon, G,
and
Basset G.
Electrolyte and fluid transport across the mature alveolar epithelium.
J Appl Physiol
74:
1-15,
1993
32.
Suzuki, S,
Noda M,
Sugita M,
Ono S,
Koike K,
and
Fujimura S.
Impairment of transalveolar fluid transport and lung Na+-K+-ATPase function by hypoxia in rats.
J Appl Physiol
87:
962-968,
1999
33.
Wang, Y,
Folkesson HG,
Jayr C,
Ware LB,
and
Matthay MA.
Alveolar epithelial fluid transport can be simultaneously upregulated by both KGF and
-agonist therapy.
J Appl Physiol
87:
1852-1860,
1999
This article has been cited by other articles:
![]() |
Z. Wang, J. Xu, G. Ma, M. Sagawa, M. Shimazaki, Y. Ueda, and T. Sakuma Chronic pulmonary artery occlusion increases alveolar fluid clearance in rats. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1213 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Snyder, K. C. Beck, S. T. Turner, E. A. Hoffman, M. J. Joyner, and B. D. Johnson Genetic variation of the beta2-adrenergic receptor is associated with differences in lung fluid accumulation in humans J Appl Physiol, June 1, 2007; 102(6): 2172 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Snyder, K. C. Beck, M. L. Hulsebus, J. F. Breen, E. A. Hoffman, and B. D. Johnson Short-term hypoxic exposure at rest and during exercise reduces lung water in healthy humans J Appl Physiol, December 1, 2006; 101(6): 1623 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Azzam, Y. Adir, A. Crespo, A. Comellas, E. Lecuona, L. A. Dada, N. Krivoy, D. H. Rutschman, J. I. Sznajder, and K. M. Ridge Norepinephrine Increases Alveolar Fluid Reabsorption and Na,K-ATPase Activity Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 730 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sakuma, Y. Zhao, M. Sugita, M. Sagawa, H. Toga, T. Ishibashi, M. Nishio, and M. A. Matthay Malnutrition impairs alveolar fluid clearance in rat lungs Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1268 - L1274. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||